Molecular probing of TNF: From identification of therapeutic target to guidance of therapy in inflammatory diseases

Cong Qiu Chu

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Therapy by blocking tumor necrosis factor (TNF) activity is highly efficacious and profoundly changed the paradigm of several inflammatory diseases. However, a significant proportion of patients with inflammatory diseases do not respond to TNF inhibitors (TNFi). Prediction of therapeutic response is required for TNFi therapy. Isotope labeled anti-TNF antibodies or TNF receptor have been investigated to localize TNF production at inflammatory tissue in animal models and in patients with inflammatory diseases. The in vivo detection of TNF has been associated with treatment response. Recently, fluorophore labeled anti-TNF antibody in combination with confocal laser endomicroscopy in patients with Crohn's disease yielded more accurate and quantitative in vivo detection of TNF in the diseased mucosa. More importantly, this method demonstrated high therapeutic predication value. Fluorophore labeled TNF binding aptamers in combination with modern imaging technology offers additional tools for in vivo TNF probing.

Original languageEnglish (US)
Pages (from-to)64-69
Number of pages6
JournalCytokine
Volume101
DOIs
StatePublished - Jan 2018

Keywords

  • In vivo probing
  • TNF
  • Therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Biochemistry
  • Hematology
  • Molecular Biology

Fingerprint Dive into the research topics of 'Molecular probing of TNF: From identification of therapeutic target to guidance of therapy in inflammatory diseases'. Together they form a unique fingerprint.

Cite this